{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:24:40Z","timestamp":1781004280372,"version":"3.54.1"},"reference-count":56,"publisher":"Archives of Endocrinology and Metabolism","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Endocrinol. Metab."],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1590\/2359-3997000000299","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T22:57:31Z","timestamp":1510786651000},"page":"490-500","source":"Crossref","is-referenced-by-count":18,"title":["The clinical genetics of phaeochromocytoma and paraganglioma"],"prefix":"10.20945","volume":"61","author":[{"given":"P. T.","family":"Kavinga Gunawardane","sequence":"first","affiliation":[{"name":"University of Oxford,  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Grossman","sequence":"additional","affiliation":[{"name":"University of Oxford,  UK; University of Oxford,  UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jc.2010-1946","article-title":"Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators","volume":"96","author":"Ayala-Ramirez M","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0032-1304594","article-title":"A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma","volume":"44","author":"Buffet A","year":"2012","journal-title":"Horm Metab Res"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders JW","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing","volume":"91","author":"Brouwers FM","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MED.0b013e32835fcc45","article-title":"Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options","volume":"20","author":"Vicha A","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","author":"Dahia PL","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"ref7","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","article-title":"Pheochromocytoma: the expanding genetic differential diagnosis","volume":"95","author":"Bryant J","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2265.1998.3751208.x","article-title":"Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma","volume":"48","author":"Pomares FJ","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref9","first-page":"101","article-title":"Multiple endocrine neoplasia type 2: 2007 update","volume":"68","author":"Raue F","year":"2007","journal-title":"Horm Res"},{"issue":"7","key":"ref10","first-page":"1989","article-title":"Genetic basis of endocrine disease: multiple endocrine neoplasia type 2","volume":"80","author":"Mulligan LM","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"9486","key":"ref11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders JW","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.14310\/horm.2002.1227","article-title":"Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome","volume":"8","author":"Pacak K","year":"2009","journal-title":"Hormones (Athens)"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","author":"Eisenhofer G","year":"2011","journal-title":"Clin Chem"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"von Recklinghausen\u2019s disease and pheochromocytomas","volume":"162","author":"Walther MM","year":"1999","journal-title":"J Urol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21","volume":"63","author":"Martin GA","year":"1990","journal-title":"Cell"},{"key":"ref16","series-title":"Neurofibromatosis: Phenotype, natural history, and pathogenesis","author":"Riccardi VM","year":"1992"},{"issue":"2","key":"ref17","first-page":"305","article-title":"An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes","volume":"53","author":"Easton DF","year":"1993","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jmg.33.1.2","article-title":"Molecular genetics of neurofibromatosis type 1 (NF1)","volume":"33","author":"Shen MH","year":"1996","journal-title":"J Med Genet"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N","article-title":"Do NF1 gene deletions result in a characteristic phenotype?","volume":"73","author":"Tonsgard JH","year":"1997","journal-title":"Am J Med Genet"},{"issue":"5","key":"ref20","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"issue":"25","key":"ref21","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1056\/NEJMc066006","article-title":"Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma","volume":"354","author":"Bausch B","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3171\/jns.2003.98.1.0082","article-title":"The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease","volume":"98","author":"Wanebo JE","year":"2003","journal-title":"J Neurosurg"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0161-6420(01)00758-8","article-title":"Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease","volume":"108","author":"Singh AD","year":"2001","journal-title":"Ophthalmology"},{"issue":"5112","key":"ref24","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel-Lindau disease tumor suppressor gene","volume":"260","author":"Latif F","year":"1993","journal-title":"Science"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/jhh.2012.20","article-title":"An update on the genetics of pheochromocytoma","volume":"27","author":"Karasek D","year":"2013","journal-title":"J Hum Hypertens"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1210\/jc.2009-0354","article-title":"Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2","volume":"94","author":"Boedeker CC","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes","volume":"86","author":"Eisenhofer G","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/381054","article-title":"Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma","volume":"74","author":"Vanharanta S","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.1009199108","article-title":"Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations","volume":"108","author":"Janeway KA","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort","volume":"100","author":"D\u00e9nes J","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-13-0623","article-title":"Non-pheochromocytoma (PCC)\/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis","volume":"170","author":"Papathomas TG","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.beem.2010.10.004","article-title":"Pheochromocytomas: the (pseudo)-hypoxia hypothesis","volume":"24","author":"Favier J","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"18","key":"ref33","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-16-0473","article-title":"A Small-Molecule Antagonist of HIF2\u03b1 Is Efficacious in Preclinical Models of Renal Cell Carcinoma","volume":"76","author":"Wallace EM","year":"2016","journal-title":"Cancer Res"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"C9","DOI":"10.1530\/ERC-16-0479","article-title":"New HIF2\u03b1 inhibitors: potential implications as therapeutics for advanced pheochromocytomas and paragangliomas","volume":"24","author":"Toledo RA","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"Neumann HP1","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10689-010-9402-1","article-title":"Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma","volume":"10","author":"Hensen EF","year":"2011","journal-title":"Fam Cancer"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti D","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/humu.21136","article-title":"Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD","volume":"31","author":"Ricketts CJ","year":"2010","journal-title":"Hum Mutat"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S1470-2045(09)70164-0","article-title":"An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis","volume":"10","author":"van Nederveen FH","year":"2009","journal-title":"Lancet Oncol"},{"issue":"8","key":"ref40","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2008-2504","article-title":"PGL. NET network. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas","volume":"94","author":"Burnichon N","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek E","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"ref42","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1001\/jama.2010.1830","article-title":"Spectrum and prevalence of FP\/TMEM127 gene mutations in pheochromocytomas and paragangliomas","volume":"304","author":"Yao L","year":"2010","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1101\/gad.6.1.71","article-title":"Myc and Max associate in vivo","volume":"6","author":"Blackwood EM","year":"1992","journal-title":"Genes Dev"},{"issue":"13","key":"ref44","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: a heritable breakup","volume":"72","author":"Casc\u00f3n A","year":"2012","journal-title":"Cancer Res"},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez I","year":"2011","journal-title":"Nat Genet"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1101\/gad.1648608","article-title":"The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor","volume":"22","author":"Schlisio S","year":"2008","journal-title":"Genes Dev"},{"issue":"25","key":"ref47","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","author":"Ladroue C","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","author":"Castro-Vega LJ","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Casc\u00f3n A","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"ref50","doi-asserted-by":"crossref","first-page":"E1266","DOI":"10.1210\/jc.2012-4257","article-title":"Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing","volume":"98","author":"Crona J","year":"2013","journal-title":"J J Clin Endocrinol Metab"},{"issue":"13","key":"ref51","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","article-title":"New syndrome of paraganglioma and somatostatinoma associated with polycythemia","volume":"31","author":"Pacak K","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"ref52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma","volume":"31","author":"Fishbein L","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2008-2419","article-title":"Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas","volume":"94","author":"Mannelli M","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref54","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-017-1310-9","article-title":"Routine genetic screening with a multi-gene panel in patients with pheochromocytomas","author":"Sbardella E","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/cen.12530","article-title":"Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review","volume":"82","author":"Brito JP","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","author":"Toledo RA","year":"2017","journal-title":"Nat Rev Endocrinol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/aem\/v61n5\/0004-2730-aem-61-5-0490.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T16:20:17Z","timestamp":1527697217000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972017000500490&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2359-39972017000500490"],"URL":"https:\/\/doi.org\/10.1590\/2359-3997000000299","relation":{},"ISSN":["2359-3997"],"issn-type":[{"value":"2359-3997","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}